TitleGrowth factor-triggered de-sialylation controls glycolipid-lectin-driven endocytosis.
Publication TypeJournal Article
Year of Publication2025
AuthorsMacDonald E, Forrester A, Valades-Cruz CA, Madsen TD, Hetmanski JHR, Dransart E, Ng Y, Godbole R, Shp AAkhil, Leconte L, Chambon V, Ghosh D, Pinet A, Bhatia D, Lombard B, Loew D, Larsen MR, Leffler H, Lefeber DJ, Clausen H, Blangy A, Caswell P, Shafaq-Zadah M, Mayor S, Weigert R, Wunder C, Johannes L
JournalNat Cell Biol
Date Published2025 Feb 21
ISSN1476-4679
Abstract

Glycolipid-lectin-driven endocytosis controls the formation of clathrin-independent carriers and the internalization of various cargos such as β1 integrin. Whether this process is regulated in a dynamic manner remained unexplored. Here we demonstrate that, within minutes, the epidermal growth factor triggers the galectin-driven endocytosis of cell-surface glycoproteins, such as integrins, that are key regulators of cell adhesion and migration. The onset of this process-mediated by the Na/H antiporter NHE1 as well as the neuraminidases Neu1 and Neu3-requires the pH-triggered enzymatic removal of sialic acids whose presence otherwise prevents galectin binding. De-sialylated glycoproteins are then retrogradely transported to the Golgi apparatus where their glycan make-up is reset to regulate EGF-dependent invasive-cell migration. Further evidence is provided for a role of neuraminidases and galectin-3 in acidification-dependent bone resorption. Glycosylation at the cell surface thereby emerges as a dynamic and reversible regulatory post-translational modification that controls a highly adaptable trafficking pathway.

URLhttps://pubmed.ncbi.nlm.nih.gov/39984654/
DOI10.1038/s41556-025-01616-x
Alternate JournalNat Cell Biol
PubMed ID39984654
PubMed Central ID2914105
Grant ListANR-10-IDEX-0001-02 PSL / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-17-CONV-0005 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-19-CE13-0001-01 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-20-CE15-0009-01 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-22-CE11-0030-03 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-11-LABX-0043 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR11-LABX-0038 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR10-INBS-01 / / Agence Nationale de la Recherche (French National Research Agency) /
ANR-10-INBS-04-07 / / Agence Nationale de la Recherche (French National Research Agency) /
n°200014 / / Mizutani Foundation for Glycoscience (Mizutani Foundation) /
NNF0067602 / / Novo Nordisk Fonden (Novo Nordisk Foundation) /
DNRF107 / / Novo Nordisk Fonden (Novo Nordisk Foundation) /
DCRPGF\100002go / / Cancer Research UK (CRUK) /
203128/A/16/Z / / Wellcome Trust (Wellcome) /
226804/Z/22/Z / / Wellcome Trust (Wellcome) /
LIP-2021-017 / / Leverhulme Trust /